Literature DB >> 8012386

Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation.

K M Felsenstein1, L W Hunihan, S B Roberts.   

Abstract

Mutations within the beta-amyloid precursor protein gene cosegregate with the early-onset form of familial Alzheimer's Disease (FAD). It is not known how these mutations result in disease; however, one early-onset AD mutation in a Swedish kindred increases potentially amyloidogenic fragments and beta-protein production in cells expressing the mutant beta-APP. Using a novel recombinant reporter system we found a qualitative change in the secreted product, from cleavage within the beta-protein sequence to cleavage near the N-terminal region of the beta-protein, even though the total amount of secreted mutant product is similar to wild-type. The results suggest that the increased formation of potentially amyloidogenic fragments in cells expressing the Swedish FAD occurs by enzymatic cleavage in the secretory pathway. Alterations in the secretory process may predispose an individual to AD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012386     DOI: 10.1038/ng0394-251

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  22 in total

1.  Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy.

Authors:  R Christie; M Yamada; M Moskowitz; B Hyman
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Authors:  Kunihiro Uryu; Helmut Laurer; Tracy McIntosh; Domenico Praticò; Daniel Martinez; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

3.  The metalloprotease meprin β generates amino terminal-truncated amyloid β peptide species.

Authors:  Jessica Bien; Tamara Jefferson; Mirsada Causević; Thorsten Jumpertz; Lisa Munter; Gerd Multhaup; Sascha Weggen; Christoph Becker-Pauly; Claus U Pietrzik
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

4.  Effect of protein kinase A inhibitors on the production of Abeta40 and Abeta42 by human cells expressing normal and Alzheimer's disease-linked mutated betaAPP and presenilin 1.

Authors:  P Marambaud; K Ancolio; C Alves da Costa; F Checler
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.

Authors:  D M Mann; T Iwatsubo; Y Ihara; N J Cairns; P L Lantos; N Bogdanovic; L Lannfelt; B Winblad; M L Maat-Schieman; M N Rossor
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.

Authors:  S Y Guénette; J Chen; P D Jondro; R E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

Authors:  M Citron; C Vigo-Pelfrey; D B Teplow; C Miller; D Schenk; J Johnston; B Winblad; N Venizelos; L Lannfelt; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

8.  Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.

Authors:  Ayano Kimura; Saori Hata; Toshiharu Suzuki
Journal:  J Biol Chem       Date:  2016-09-29       Impact factor: 5.157

Review 9.  Behavior of neural stem cells in the Alzheimer brain.

Authors:  B Waldau; A K Shetty
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

Review 10.  An update on the amyloid hypothesis.

Authors:  Christopher B Eckman; Elizabeth A Eckman
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.